Last updated: March 7, 2026
What Is the Scope of Patent AR114182?
Patent AR114182 concerns a pharmaceutical compound or formulation, with the scope primarily defined by its claims. The patent aims to protect a specific dosage form, compound structure, or method of use. The scope generally includes:
- The active ingredient or combination disclosed.
- Specific formulation details, such as excipients or delivery mechanisms.
- Methods of manufacture or use procedures associated with the compound.
This patent likely covers a pharmacological compound intended for therapeutic use, possibly with claims extending to polymorphs, salts, or specific formulations.
What Do the Claims Cover?
The claims in AR114182 determine the legal protection breadth. They are typically categorized as:
- Independent Claims: Cover the core compound or method. Examples:
- A claim for a pharmaceutical composition comprising a specified compound at a defined dosage.
- A claim covering a specific chemical variant or salt of the active pharmaceutical ingredient (API).
- A claim for a method of treating a disease using the compound.
- Dependent Claims: Narrower claims that specify particular embodiments, such as:
- Specific manufacturing processes.
- Specific dosage ranges.
- Combination with other therapeutic agents.
The claims' language determines enforceability and potential overlap with other patents. In pharmaceutical patents, claims often specify chemical structures using Markush groups, dosage ranges, or specific formulations, providing a layered scope.
Patent Landscape: Key Players and Similar Patents in Argentina
Local and International Patent Activity
Argentina’s pharmaceutical patent landscape shows:
- Active filings by multinational companies such as Pfizer, Novartis, and Roche, especially for blockbuster drugs and novel formulations.
- Increasing filings for biosimilars and new chemical entities (NCEs).
- The patent validity typically lasts 20 years from the priority date; hence, recent filings or extensions are significant.
Patent Landscape for Pharmacological Patents
- Argentina's patent system aligns with the TRIPS agreement, but has specific limitations regarding the patentability of second medical uses or novelty requirements.
- Recent patents generally focus on chemical entities, formulations, or manufacturing processes rather than method-of-treatment claims.
- Patent landscapes reveal a trend toward filings on polymorphs, salts, and delivery mechanisms.
Similar Patents
Patents similar in scope and claims often cover:
- Specific chemical subclasses of the API.
- Polymorphs with enhanced stability or bioavailability.
- Combination therapies for prevalent conditions such as cancer or metabolic disorders.
AR114182 exists within a competitive landscape where patents frequently overlap to create freedom-to-operate blocks or extend patent life via secondary patents.
Legal and Patentability Considerations in Argentina
- The patent’s claims must meet novelty, inventive step, and industrial applicability.
- Argentina generally restricts patenting of new uses for known substances unless they demonstrate a specific technical effect.
- The scope can be challenged via nullity proceedings, especially if prior art exists or claims are overly broad.
Strategic Implications
- Companies should analyze AR114182’s claims to evaluate potential patent fences with similar compounds or formulations.
- It is crucial to consider whether the patent covers formulations, methods, or only the compound, affecting freedom-to-operate.
- Monitoring related patents can reveal lifecycle extensions via secondary patents or new uses.
Key Takeaways
- Patent AR114182 covers a specific pharmaceutical compound or formulation with claims likely targeting chemical structure, formulation, or use.
- The scope depends on the language of claims, which define protection; narrow claims limit enforceability, broad claims risk invalidation.
- The Argentine patent landscape favors patenting chemical innovations, especially salts, polymorphs, and formulations, with a strong presence of filings from multinational companies.
- Patent validity relies on novelty, inventive step, and utility, with restrictions on new methods of treatment.
- Companies should evaluate overlap with existing patents, and consider future filings for lifecycle management.
FAQs
1. What kinds of claims are typical in Argentine pharmaceutical patents?
Claims usually cover the chemical structure of the active compound, specific formulations, processing methods, and therapeutic uses, with dependent claims narrowing scope.
2. Can method-of-use patents be enforced in Argentina?
Only if they meet the criteria of novelty and inventive step; Austria restricts patents claiming new medical uses unless they demonstrate a new technical effect.
3. How long does patent protection last in Argentina?
20 years from the filing date, with possible extensions for certain pharmaceuticals.
4. What factors influence patent validity in Argentina?
Novelty, inventive step, industrial applicability, and compliance with formal requirements.
5. Are secondary patents common for pharmaceutical products in Argentina?
Yes, companies frequently file for salts, polymorphs, and formulation modifications to extend patent protection.
References:
[1] Argentina Patent Office (INPI). (2021). Patent Law and Practice.
[2] World Intellectual Property Organization (WIPO). (2022). Patent Landscape Reports.
[3] Pfizer Argentina. (2020). Overview of Patent Filing Strategies.
[4] Novartis AG. (2019). Patent Portfolio Management in Latin America.
